Market Tracker

09/26 5:16pm ET

Sarepta Therapeutics Inc (NASDAQ:SRPT)

59.66
Delayed Data
As of 3:59pm ET
 +1.83 / +3.16%
Today’s Change
8.00
Today|||52-Week Range
61.60
+54.64%
Year-to-Date
There's No Debate, Dip Buyers Are Jittery
11:19am / TheStreet.com - Paid Partner Content
I Am One of the Underinvested Bulls Right Now
Sep 22 / TheStreet.com - Paid Partner Content
For Traders, Planning Is More Important Than the Plan
Sep 25 / TheStreet.com - Paid Partner Content
Stock Futures Rise as Wall Street Finds Relief in a Patient Fed
Sep 22 / TheStreet.com - Paid Partner Content
The Woman Behind Sarepta Therapeutics' Success
Sep 24 / MotleyFool.com - Paid Partner Content
Sarepta (SRPT) Stock Slides in After-Hours Trading on Public Offering
Sep 21 / TheStreet.com - Paid Partner Content
2 Stocks I'd Never Buy, and 1 I'll Consider
Sep 23 / MotleyFool.com - Paid Partner Content
Sarepta (SRPT) Stock Lower, BioMarin to Appeal Patent Ruling
Sep 21 / TheStreet.com - Paid Partner Content
5 Stocks With Amazon-Like Growth Potential
Sep 22 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD ...
Sep 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close57.83
Today’s open58.99
Day’s range58.00 - 61.43
Volume5,960,201
Average volume (3 months)4,745,686
Market cap$2.8B
Dividend yield--
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)-53.39%
Earnings growth (this year)+2.54%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)-87.16%
P/E ratioNM
Price/Sales1,302.11
Price/Book13.86

Competitors

----
GWPHGW Pharmaceuticals P...+18.50+17.20%
MDCOMedicines Co-0.64-1.58%
RAREUltragenyx Pharmaceu...-1.35-1.86%
Data as of 3:59pm ET, 09/26/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$1.28
Annual revenue (last year)$1.3M
Annual profit (last year)-$220.0M
Net profit margin-17,560.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive &
Medical Officer
Edward M. Kaye
Head-Operations &
Vice President
Gavin T. Malenfant
Corporate headquarters
Cambridge, Massachusetts

Forecasts